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clinical ﬁndings that obesity and malalignment cause increased
risks for incidence of OA, and that the combination of obesity and
malalignment further increases risks. The extent of risk attributed
to malalignment has been controversial, perhaps due to different
methods in OA detection or alignment measures. Our modeling
approach, combined with detailed comparisons to clinical data,
offers a powerful tool to better understand the etiology and pro-
gression of knee OA, and may help us develop more effective
exercise and treatment plans.
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MICRORNA-27b (miR-27b) REGULATES THE EXPRESSION
OF MMP-13 IN HUMAN OSTEOARTHRITIS CHONDROCYTES
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Purpose: MicroRNA (miRNA)-mediated RNA interference (RNAi)
is a novel evolutionarily conserved mechanism for the regulation
of gene expression at the post-transcriptional level. In this study
we determined the posttranscriptional regulation of MMP-13 by
miRNAs in human chondrocytes.
Methods: Cartilage specimens were washed with sterile PBS and
the macroscopic cartilage degeneration was determined by stain-
ing of femoral head samples with India ink. Cartilage with smooth
articular surface was resected and used to prepare chondro-
cytes by enzymatic digestion (OA chondrocytes) and these were
cultured at high density in monolayer. Expression of chondrocyte-
speciﬁc genes was determined by RT-PCR. Chondrocytes were
stimulated with interleukin-1β (5ng/ml) in vitro and total RNA was
prepared using TRIZOL reagent and miRNA was puriﬁed using
the mirVANA system. Expression of argonuate and Dicer mR-
NAs was determined by RT-PCR and of Dicer protein by Western
immunoblotting. MicroRNA isolated from IL-1β stimulated and non-
stimulated chondrocytes was poly-A tailed and cDNA synthesized
using a commercially available kit. Poly-A tailed cDNA was mixed
with RT2 SYBR Green qPCR master mix in 96 well plates contain-
ing predispensed primers speciﬁc for 352 known human miRNAs.
Real-time PCR ampliﬁcation was performed using the StepOne
Real Time PCR System and Ct method was used to calculate
the relative expression of miRNAs and miRNAs with fold change
of 2 or higher were considered to be differentially expressed.
Expression of MMP-13 and miR-27b was quantiﬁed using Taq-
Man Assays. Transfection with a reporter construct and miRNA
mimic was employed to verify the suppression of MMP-13 mRNA.
Role of p38, JNK and ERK1/2 MAPKs and NF-κB in regulating
miR-27b and MMP-13 expression in OA chondrocytes was evalu-
ated using speciﬁc inhibitors. Gene expression data was analyzed
using Origin 6.1 software package and P<0.05 was considered
signiﬁcant.
Results: Human OA chondrocytes express transcripts for Dicer1
and AGO 2-4 genes and Dicer protein. We also identiﬁed 44
differentially expressed miRNAs in human OA chondrocytes stim-
ulated with IL-1β for 6 h. We found 2 miRNAs- miR-146a and
miR-491_3p-were up-regulated and 42 miRNAs, including miR-
27b (∼3.21 fold), were signiﬁcantly down-regulated (P<0.05). Tar-
getScanS and PicTar both identiﬁed sequences conserved in the
3’UTR of MMP-13 complementary to miR-27b "seed sequence".
Chondrocytes stimulated with IL-1β had signiﬁcantly low levels
of miR-27b expression (P<0.001) and produced high levels of
MMP-13 protein in culture supernatant. Overexpression of miR-
27b inhibited the IL-1β -induced production of MMP-13 protein.
HeLa cells (which do not express mir-27b) transiently cotrans-
fected with the reporter plasmid and miR-27b mimic (10 nM and
100 nM) showed markedly reduced luciferase activity. Human OA
chondrocytes pretreated with the NF-κB inhibitor MG132 had 5 fold
higher expression of miR-27b compared to controls. Chondrocytes
pretreated with the p38-MAPK inhibitor SB202190 showed ∼74%
increase in miR-27b expression and an increase of ∼87% in miR-
27b expression was found in chondrocytes pretreated with the
JNK inhibitor SP600125. These data indicate that activated NF-κB
and MAPKs, which are necessary for the induction and expression
of MMP-13 are negative regulators of miR-27b expression in OA
chondrocytes.
Figure 1. Expression of MMP-13 and mir-27b in control and IL-1β-stimulated
human OA chondrocytes in vitro.
Conclusions: These results identify a novel miRNA, miR-27b
as a posttranscriptional regulator of MMP-13 expression and up-
regulation of miR-27b or preventing its down regulation in vivo may
present a novel therapeutic and preventive approach for OA.
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Purpose: Although SOX9 is a key molecule for chondrogenic
differentiation, little is known about the upstream signal. Aiming
at elucidation of molecular network underlying the chondrogenic
differentiation, this study attempted to identify transcription factors
to induce SOX9 expression and examined the function.
Methods: Sequences of about 4 kb of 5’-end ﬂanking regions of
human, mouse and chick SOX9 genes were compared using the
BLASTN search. In vivo localization was examined by immunohis-
tochemistry in the limb cartilage of fetal mice (E17.5). Promoter
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activities of SOX9, SOX6, and type II collagen (COL2A1) genes
were determined by luciferase assays in human non-chondrogenic
HeLa cells and mouse chondrogenic ATDC5 cells transfected with
a reporter gene containing the respective promoter fragments.
Protein-DNA binding was examined by electrophoretic mobility
shift assay (EMSA) and chromatin immunoprecipitation (ChIP) as-
say. Chondrogenic differentiation was assessed by endogenous
SOX9, SOX6, and COL2A1 mRNA levels using real-time RT-PCR,
and by Alcian blue staining and alkaline phosphatase activity. For
the functional analyses, we established stable lines of HeLa and
ATDC5 cells with retroviral overexpression of RelA or the control
empty vector (EV). To know the physiological role, we compared
the skeletal phenotypes histologically between homozygous deﬁ-
cient (-/-) mice and the wild-type littermates.
Results: Exhaustive comparison of the sequences of the SOX9
promoters among species found that the 1.0 kb upstream of the
transcriptional start site was about 80% conserved, in which the
binding motifs of nuclear factor kappaB (NF-κB), NFAT, AP-1, Sp-1,
CREB, CCAAT, and GATA were identiﬁed. When expression vec-
tors of 31 putative transcription factors for the seven identiﬁed mo-
tifs were co-transfected in HeLa and ATDC5 cells transfected with
a reporter construct containing the 1.0 kb SOX9 promoter, RelA
(NF-κB p65), an NF-κB family member, most strongly activated the
promoter activity. RelA and SOX9 were well co-localized in rest-
ing, pre-hypertrophic and hypertrophic chondrocytes of the limb
cartilage. The deletion, mutagenesis, and tandem-repeat analyses
of the luciferase assay in HeLa and ATDC5 cells co-transfected
with RelA or the control EV identiﬁed the core region responsive
to RelA between -266 and -228 bp relative to the transcriptional
start site of the human SOX9 gene. This region contained the
NF-κB motif which was the only fully-matched sequence in the
proximal SOX9 promoter. EMSA revealed the complex formation
of the in vitro-translated RelA protein with the 39 bp NF-κB motif
oligonucleotide probe, and the speciﬁcity was conﬁrmed by the
probe mutagenesis, the cold competition with excess amounts of
wild-type and mutated unlabelled probes, and the supershift by
addition of an antibody to RelA. ChIP assay conﬁrmed the in vivo
speciﬁc binding of RelA and the NF-κB motif, which was abolished
when using non-immune IgG or a primer set that does not span
the NF-kB motif. The RelA overexpression in HeLa and ATDC5
cells stimulated the chondrogenic differentiation parameters and
promoter activities of SOX6 and COL2A1 genes, as compared to
the control EV. Finally, the RelA-/- mice exhibited dwarﬁsm from
embryonic stages with about a half lengths of limbs and trunks
compared to those of the wild-type littermates (E15.5), which
was associated with suppression of several steps of chondrogenic
differentiation.
Conclusions: We have identiﬁed RelA as a transcriptional factor
for SOX9 induction via binding to an NF-κB binding motif in the
promoter. The RelA/SOX9 signal is essential for chondrogenic
differentiation and skeletal growth.
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Purpose: Osteoarthritis (OA) is a degenerative joint disease char-
acterized by cartilage degeneration, synovial inﬂammation, and
bone changes. In clinical end stage OA subchondral bone scle-
roses is frequently present, represented by an increased volume
of trabecular bone and cortical plate. However, in animal models
where early features of OA are studied, trabecular bone volume
and plate thickness decreases. It is unclear whether these early
changes are intrinsic to the osteoarthritis process and indepen-
dent of the cause of OA induction. Alternatively, they might be
caused by a change in joint mechanics and are related to kind of
model used. In this study, early bone changes in different canine
models of OA are evaluated in relation to cartilage changes and
mechanical variables.
Methods: Epiphyseal and metaphyseal bone changes were eval-
uated by micro-CT in the canine bilateral ACLT model (n=6),
the bilateral Groove model (n=6) and the unilateral ACLT medial
meniscectomy model (n=13), after 20, 20 and 12 weeks of OA
induction respectively. Cartilage damage was evaluated by his-
tology and proteoglycan content levels. In addition, in the two
bilateral models hydroxylysylpyridinoline (HP) and lysylpyridinoline
(LP) levels in urine were evaluated over time as indication of bone
resorption.
Results: The subchondral plate thickness decreased in both bi-
lateral models, reﬂected by an increased bone resorption shortly
after operation. However, trabecular bone changes occurred only
in the ACLT model and extended to the metaphyseal bone, which
suggests a causative relation with joint (un)loading. Cartilage dam-
age was similar in the bilateral ACLT and Groove model. In the
unilateral ACLT medial meniscectomy model, cartilage changes
were more severe on the medial side, while on the lateral (less
loaded) side trabecular bone changes were more severe. Inter-
estingly, thinning of the subchondral plate was not present on the
lateral side, but did accompany the severe cartilage degeneration
on the medial side.
Conclusions: These results show that thinning of the subchon-
dral plate is intrinsic to the process of cartilage degeneration.
The induction of OA seems to disrupt bone production locally,
either biochemical or biomechanical, which might eventually lead
to subchondral sclerosis. In addition, trabecular bone volume de-
creased when joint loading is disturbed. The signiﬁcance of an
early decrease of plate thickness and trabecular volume in OA de-
velopment is still unclear. Previous studies postulated a protective
role of the softening of bone which results in secondary unloading
of cartilage. This concept is effectively applied in osteoarthritis
treatments like joint distraction and bisphosphonate therapy.
Acknowledgements: This study was ﬁnancially supported by the
Anna Fund and the Dutch Arthritis Association.
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THE UNDERLYING MOLECULAR MECHANISMS OF
PRIMARY HIP OSTEOARTHRITIS AND ITS INVERSE
RELATIONSHIP WITH FRACTURE COHORTS
D.D. Kumarasinghe1,2, B. Hopwood2,3, G.J. Atkins3,4,
N.L. Fazzalari1,2
1Discipline of Pathology, Univ. of Adelaide, Adelaide, Australia;
2Bone & Joint Res. Lab, SA Pathology, Adelaide, Australia;
3Hanson Inst., SA Pathology, Adelaide, Australia; 4Discipline of
Orthopaedics & Trauma, Univ. of Adelaide, Adelaide, Australia
Purpose: Primary hip osteoarthritis (OA) is a common cause
of disability, and costs the US and Australian economies billions
of dollars each year. There is increasing evidence that systemic
changes in the trabecular bone are an underlying cause. Differen-
tial gene expression observed between OA and controls through
microarray analysis of trabecular bone from the intertrochanteric
(IT) region has raised several candidates, including genes from
the WNT and TGFβ signalling pathways; both have established
roles in osteoblast cell biology. As such an investigation in primary
